NFE2L2 and Parkinson disease: NRF2 activators have also been suggested to be neuroprotective against Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD)6,8–14 on the basis of results in animal models of these neurodegenerative disorders.